Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects

NCT00953888 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AZD5069
DRUG: Placebo

Sponsor

AstraZeneca